Article Text

Download PDFPDF
Mycophenolate mofetil for the treatment of severe inflammatory external eye diseases
  1. M R Wilkins,
  2. J K G Dart
  1. The Corneal and External Disease Service, Moorfields Eye Hospital, London UK
  1. Mark R Wilkins, Moorfields Eye Hospital, City Road, London EC1V 2PD, UK; mail{at}

Statistics from

Mycophenolate mofetil (MMF) is a systemic immunosuppressive agent widely used to prevent solid organ transplant rejection. It has also been used to treat a variety of systemic autoimmune conditions.13 Several papers have described its use to treat predominantly posterior segment ocular inflammatory conditions.47 We have reviewed our experience using MMF to treat anterior segment conditions.

Case series

From our immunosuppression database and electronic patient records we identified patients in the hospital who had taken MMF to treat severe inflammatory external eye conditions.

Patient response to MMF treatment was classified as success—no inflammation after induction MMF treatment either as monotherapy …

View Full Text


  • Competing interests: None.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.